Home Nieuwsarchief
maandag, 27. augustus 2012
Nieuws op de website
II. Synthia’s (not so) revolutionary character

The announcement of the first self-replicating synthetic bacterial cell by the J. Craig Venter Institute (JCVI) in May 2010 caught worldwide media coverage. ‘This is not (yet) new life’, the general comments read. Or, as Craig Venter put it himself: “It is not life from scratch.”

 

Venter called the work “a baby step” in the field of synthetic biology. But ultimately, as he explained to the Health and Energy Committee on Energy and Commerce in the US House of Representatives, “Synthetic genomics is different [from standard molecular biology/genetic engineering] in that scientists start with digital information in the computer, which allows for the design of entire synthetic chromosomes to replace existing chromosomes in cells.”

Disruptive character

The question of ‘newness’ and the revolutionary or even disruptive character of synthetic biology is not only a purely scientific issue. It is highly relevant for society, and has strategic dimensions. For instance: the answer to the question of newness is decisive for decisions on research and regulatory policies. On the one hand, scientists and research institutes will tend to define synthetic biology as ‘new’ when they want to attract new investments. On the other hand, really new approaches in biology will trigger policy makers to call for stricter or new regulation. Moreover, the question whether ‘new life forms’ can be created or not, will influence public perception and acceptance.

Philosophical watershed?

A comment in the Vatican’s official newspaper (L’Osservatore Romano) on the self-replicating synthetic bacterium, stated that “It is not the creation of life, but the replacement of one of its motors”. It is illustrative for the majority of the institutional comments that JCVI’s achievement is not a philosophical watershed. In a public panel discussion about synthetic biology organised by the German Ethics Council, some of the participants likewise called for a “de-dramaticising” of the issue. On the other hand, President Obama asked his bioethics commission to study the implications of the JCVI research in a broad sense, suggesting that synthetic biology may raise new issues. This commission is expected to make recommendations on "any actions the Federal government should take to ensure that America reaps the benefits of this developing field of science while identifying appropriate ethical boundaries and minimizing identified risks" before the end of the year.


More about JVCI’s achievement

Alla Katsnelson. Nature News, 20 May, 2010

Craig Venter. The implications of our Synthetic cell, New Scientist 2762, p. 3, 26 May 2010.

Prepared Statement Of J. Craig Venter, Ph.D. Before The U.S. House Of Representatives Committee On Energy And Commerce, May 27, 2010

 


More about comments

Mildred K. Cho and David A. Relman. Synthetic “Life,” Ethics, National Security, and Public Discourse, Science Vol 329, pp 38-39, 2 July 2010, DOI: 10.1126/science.1193749

Gregory Kaebnik. Is the “Synthetic Cell” about life?, The Scientist Vol. 24, Issue 7, p. 27, 1 July, 2010

Synthetic Bacteria Cell ‘Not Life’, Says Vatican, Arab Times, May 21

Nanowerk. "Synthetic biology and life: German Ethics Council encourages debate." March 24, 2010. Accessed April 29, 2010


More about Obama’s bioethics commission

Barack Obama, Letter to the Presidential Commission for the Study on Bioethical issues, May 20, 2010

Jocelyn Kaiser, Bioethics Council Hears Pleas for More Oversight of Synthetic Biology, Science, July 9, 2010

 
I. Synthetic biology and the biobased economy

The production of next generation biofuels is one of the major targets for commercial application of synthetic biology. Energy production is a field of application that has considerable public support. And it is about to become big business.

In 2007 British Petroleum selected the University of California, Berkeley to lead the Energy Biosciences Institute. It is a $500 million energy research consortium with partners Lawrence Berkeley National Lab and the University of Illinois. A year ago, Craig Venter’s company, Synthetic Genomics announced a $300 million deal with Exxon Mobil. The plan is to create fuel-producing algae, in part by using synthetic genes.

On May 27, in a hearing for the Health and Energy Committee on Energy and Commerce of the U.S. House of Representatives, Jay Keasling told how the Joint BioEnergy Institute (JBEI) is exploring the potential of synthetic biology to advance the development of next generation advanced “drop-in” fuels that perform better than ethanol.

From petroleum to sugar?

Keasling is also the founder of Amyris Biotechnologies Inc. This company is one of the key players that projects the global synthetic biology market to exceed $ 4.5 billion by the year 2015. Amyris is specialized in applying synthetic biology to provide alternatives to petroleum-sourced fuels and chemicals. A brief overview of Amyris’s activities demonstrates that apart from biofuels, synthetic biology will be applied to pave the way for a bio-based economy.

The idea is to replace molecules that might otherwise be produced from petroleum, with sugarbased products. Amyris is not only applying a type of biological pathway engineering that still looks like a sophisticated mode of genetic engineering, it also builds on established interests in sugar cane production. The company demonstrates that commercial strategies are built on existing technologies and economic infrastructures.

Radical approach

Meanwhile, far more radical approaches of synthetic biology are being developed. Think of a new artificial photosynthetic material. It uses plant, bacterial, frog and fungal enzymes, by trapping them within a foam housing. Such artificial energy production platforms are more radical because they do not rely on plants or algae. They are not competing with food production, since they do not use soil. And they are far more efficient in capturing and converting energy from the sunlight since they do not have to maintain life and reproduce. But, these more radical applications may require fundamental transitions in the structure of energy production and distribution. That makes commercial incentives like the ones BP and ExxonMobil are involved in, less likely.

More about Amyris and artificial photosynthesis

Amyris Paves the Way for Sustainable Fuels and Chemical Production (PDF file)

Frogs, Foam and Fuel (PDF file)

References

Energy Biosciences Institute website: https://www.energybiosciencesinstitute.org/

Testimony by Dr. Jay Keasling, Hearing on Developments in Synthetic Genomics and Implications for Health and Energy, Committee on Energy and Commerce U.S. House of Representatives, May 27, 2010 https://energycommerce.house.gov/documents/20100527/Keasling.Testimony.05.27.2010.pdf

Global Synthetic Biology Market to Exceed $4.5 Billion by 2015, According to New Report by Global Industry Analysts, Inc., PRWeb, July 13, 2010

Antonia Regalado, Reinventing the Leaf, Scientific American (Web only), October 2010http://www.scientificamerican.com/assets/zemi/files/pdf/Reinventing_the_Leaf.pdf

 
Synthetic Biology Newsletter 01

29 November 2010

Today, the first edition of the Synthetic Biology Newsletter was published. The Synthetic Biology Newsletter is an initiative of LIS Consult and the Synthetic Biology Project of the Woodrow Wilson International Center for Scholars. The newsletter is financially supported by the Commission on Genetic Modification and the  Rathenau Institute, both in the Netherlands.

 

The full newsletter (in PDF) can be downloaded here

 

In this issue:

 

I. Synthetic biology and the bio-based economy

Who would ever believe it possible that synthetic biology would make cars drive on renewable diesel and jets fly while reducing greenhouse gas emissions? Or that synthetic biology helps to replace petroleum based products by sugar based counterparts? Oh, and did you know that frogs set the example for a super efficient foam that captures energy and removes excess carbon dioxide from the air? Read more about synthetic biology and about Amyris, one synthetic biology company that is seriously and ambitiously paving the way for a bio-based economy as our glimmering future. Read more.....

 

II. Synthia’s (not so) revolutionary character

Do we need to start worrying about potential risks for our health and security? Is synthetic biology helping us to create artificial life? Or is our first self-replicating synthetic bacterial cell ‘just the replacement of one of the motors (of life)’, as the Vatican and other institutions believe? Meanwhile, US President Obama thinks it is time for his bioethics commission to start answering some serious questions. How can the US ‘reap the benefits of this developing field of science while identifying ethical boundaries and minimizing risks? Read more.....


III. Society’s response to synthetic biology

While synthetic biology is growing as a field of science, international civil society organizations rely on their 1990s genetic engineering strategy. They focus on risks and call for a moratorium and stricter regulation. Meanwhile, scientists and public policy authorities seem to have learned their GMO lessons. The success or a failure of a potentially controversial technology, depends on the way the public perceives it. So, in Europe, public debates are blooming. Read more.....


IV. Radical biology

Stuff for our hardcore science readers…Learn how bio-engineers are working on very radical concepts of biological systems; concepts that involve the fundamental principles of genetics and cellular mechanisms. Read more.....

 
Nanocode: Interviews with CSOs in the Netherlands

4 November 2010

The objective of the NanoCode Project is to define and develop a framework aimed at supporting the successful integration and implementation, at the European level and beyond, of the Code of Conduct (CoC) for nanosciences and nanotechnologies (N&N) proposed by the European Commission in 2008.

In the context of this NanoCode Project, Schenkelaars Biotechnology Consultancy and H LIS Consult investigated the opinions of Civil Society Organisations (CSOs) in the Netherlands on the CoC for N&N and their experiences with other voluntary codes, measures and practices aimed at the responsible development of N&N. Download the full report here
 
Governance of nanotechnologies: Netherlands Country Report published

29 July, 2010

A recently published ‘Country Report’ describes the social context for the governance of nanotechnologies in the Netherlands. The report is one of the products of the ‘Nanocode project’, of a multistakeholder dialogue providing inputs to implement the European Code of Conduct for Nanosciences & Nanotechnologies Research.

This Code of Conduct, drafted by the European Commission in 2008, is complementary to existing regulations. It provides Member States, employers, research funders, researchers and more generally all individuals and civil society organisations involved or interested in nanosciences and nanotechnologies (N&N) research (“all stakeholders”) with guidelines favouring a responsible and open approach to N&N research in the Community (Commission Recommendation of 07/02/2008). Several Country Reports drafted by the Nanocode project consortium describe the current social context, governance activities, civil society’s involvement, existing nanocodes and stakeholder’s opinions.

The nanocode project is supported by the European Commission through the 7th framework programme.

The full report is available for downloading here.

 
Start Vorige 1 2 3 4 5 6 7 8 9 10 Volgende > Einde >>

Pagina 4 van 26